Desmopressin: A nontransfusional treatment of hemophilia and von Willebrand disease

P. M. Mannucci, M. Cattaneo

Research output: Contribution to journalArticlepeer-review


Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic analogue of the antidiuretic hormone L-arginine vasopressin. Because it can raise circulating levels of factor VIII and von Willebrand factor, desmopressins used for nontransfusional treatment of mild and moderate hemophilia and von Willebrand disease. Desmopressin also shortens the prolonged skin bleeding time in patients suffering from von Willebrand disease and is given to prevent or stop excessive bleeding in such conditions.

Original languageEnglish
Pages (from-to)276-280
Number of pages5
Issue number5
Publication statusPublished - 1992


  • desmopressin
  • hemophilia
  • von Willebrand disease

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Desmopressin: A nontransfusional treatment of hemophilia and von Willebrand disease'. Together they form a unique fingerprint.

Cite this